A detailed history of Private Advisor Group, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 278,699 shares of CDXS stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
278,699
Previous 275,241 1.26%
Holding current value
$1.28 Million
Previous $853,000 0.59%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$2.62 - $3.71 $9,059 - $12,829
3,458 Added 1.26%
278,699 $858,000
Q2 2024

Aug 05, 2024

BUY
$2.65 - $3.92 $116,335 - $172,088
43,900 Added 18.98%
275,241 $853,000
Q1 2024

Apr 30, 2024

BUY
$2.59 - $4.65 $108,404 - $194,625
41,855 Added 22.09%
231,341 $807,000
Q4 2023

Feb 06, 2024

BUY
$1.54 - $3.37 $10,880 - $23,809
7,065 Added 3.87%
189,486 $577,000
Q3 2023

Nov 02, 2023

BUY
$1.5 - $3.75 $70,665 - $176,662
47,110 Added 34.82%
182,421 $344,000
Q2 2023

Aug 09, 2023

BUY
$2.21 - $4.43 $32,798 - $65,745
14,841 Added 12.32%
135,311 $378,000
Q1 2023

May 10, 2023

BUY
$3.81 - $6.76 $37,090 - $65,808
9,735 Added 8.79%
120,470 $498,000
Q4 2022

Jan 18, 2023

BUY
$4.26 - $6.84 $100,859 - $161,943
23,676 Added 27.2%
110,735 $0
Q3 2022

Oct 14, 2022

BUY
$6.06 - $12.86 $55,321 - $117,398
9,129 Added 11.71%
87,059 $528,000
Q2 2022

Jul 13, 2022

BUY
$8.35 - $21.89 $55,945 - $146,663
6,700 Added 9.41%
77,930 $815,000
Q1 2022

May 12, 2022

BUY
$16.97 - $31.93 $90,789 - $170,825
5,350 Added 8.12%
71,230 $1.47 Million
Q4 2021

Feb 10, 2022

SELL
$25.61 - $41.78 $1.45 Million - $2.36 Million
-56,550 Reduced 46.19%
65,880 $2.06 Million
Q3 2021

Oct 14, 2021

BUY
$19.65 - $27.99 $2.41 Million - $3.43 Million
122,430 New
122,430 $2.85 Million
Q3 2020

Nov 02, 2020

SELL
$11.21 - $13.82 $1,121 - $1,382
-100 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$9.8 - $12.77 $980 - $1,277
100 New
100 $1,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $302M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.